<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>50</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2012</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Evaluation of the Possible Antioxidative Role of Bilirubin Protecting from Free Radical Related Illnesses in Neonates</title>
    <FirstPage>153</FirstPage>
    <LastPage>163</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Seyed Mohammad</FirstName>
        <LastName>Fereshtehnejad</LastName>
        <affiliation locale="en_US">Firoozgar Clinical Research Developmental Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Karim</FirstName>
        <LastName>Poorsattar Bejeh Mir</LastName>
        <affiliation locale="en_US">Department of Pediatrics, Head and Founder, Division of Neonatology, Amir Mazandarani General Hospital, Sari, Mazandaran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Arash</FirstName>
        <LastName>Poorsattar Bejeh Mir</LastName>
        <affiliation locale="en_US">Research Committee, Babol University of Medical Sciences and Health Services, Babol, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Parisa</FirstName>
        <LastName>Mohagheghi</LastName>
        <affiliation locale="en_US">Department of Pediatrics, Division of Neonatology, Rasoul-Akram Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>09</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">There are disparate data regarding whether bilirubin is protective or toxic during free radical&#xA0;related illness among neonates. Seventy one infants with gestational age (GA) of &lt;32 weeks and/or birth&#xA0;weight (BW) of &lt;1500 g, who survived beyond 4 weeks and completed physical examinations were enrolled&#xA0;in this study. The infants were divided into two groups based on the presence or absence of advanced&#xA0;retinopathy of prematurity (ROP), grade III intraventricular hemorrhage (IVH), grade III necrotizing&#xA0;enterocolitis (NEC), respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), sepsis or&#xA0;severe fungal infection (SFI). The mean of total serum bilirubin (TSB) of the first 14 days of life were&#xA0;measured and compared between these two groups. A significant lower TSB were found in severe form of&#xA0;ROP (P&lt;0.001), grade III NEC (P=0.008), grade III IVH (P=0.021), SFI (P=0.003) and sepsis (P=0.007) in&#xA0;comparison to mild or disease free status. Moreover, the cut-off point of 5.1 mg/dl for the mean of TSB had&#xA0;the sensitivity of 88.1% and specificity of 84.6% to detect severe grades of ROP. Also the cut-off point of&#xA0;3.25 mg/dl had 97.2% sensitivity and 100% specificity in order to distinguish SFI. It is concluded that&#xA0;bilirubin may play an antioxidant role in vivo as in vitro; and protect preterm infant against these free radical&#xA0;related disorders. Our findings suggest that not only the upper limits of serum bilirubin, but also the lower&#xA0;limits must be taking into account in order to both preventing from neurotoxic effects and free radical based&#xA0;illnesses, respectively.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/3876</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/3876/3851</pdf_url>
  </Article>
</Articles>
